Supplementary Table 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Jonathan R. Dry,Sandra Pavey,Christine A. Pratilas,Chris Harbron,Sarah Runswick,Darren Hodgson,Christine Chresta,Rose McCormack,Natalie Byrne,Mark Cockerill,Alexander Graham,Garry Beran,Andrew Cassidy,Carolyn Haggerty,Helen Brown,Gillian Ellison,Judy Dering,Barry S. Taylor,Mitchell Stark,Vanessa Bonazzi,Sugandha Ravishankar,Leisl Packer,Feng Xing,David B. Solit,Richard S. Finn,Neal Rosen,Nicholas K. Hayward,Tim French,Paul D. Smith crossref（2023）
摘要
Supplementary Table 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
更多查看译文
AI 理解论文
溯源树
样例
